BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1354156)

  • 1. [New therapy attempts in duodenal and stomach ulcers].
    Koop H
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1247-50. PubMed ID: 1354156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent studies on therapy of peptic ulcers].
    Asaka M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1750-4. PubMed ID: 10581758
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastrotsepin in the therapy and prevention of peptic ulcer exacerbations associated with Helicobacter pylori bacteriosis].
    Grigor'ev PIa; Iakovenko AV; Vasil'ev IV
    Klin Med (Mosk); 1995; 73(1):50-2. PubMed ID: 7791310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of helicobacteriosis in stomach and duodenal lesions].
    Ostrovskiĭ IM
    Ter Arkh; 1998; 70(2):73-6. PubMed ID: 9551581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
    Lamouliatte H
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
    Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
    Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer disease in the elderly.
    Cryer B; Feldman M
    Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
    [No Abstract]   [Full Text] [Related]  

  • 11. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Chassany O; Bergmann JF
    Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
    [No Abstract]   [Full Text] [Related]  

  • 12. [The results of dynamic observation over patients with stomach and duodenum ulcer diseases after Helicobacter pylori eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2007; (4):19-24. PubMed ID: 18409486
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple therapy and Helicobacter pylori.
    Davis S
    Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 16. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of the anti-Helicobacter therapy on the life quality of patients with duodenal ulcers].
    Guseĭnzade MG
    Eksp Klin Gastroenterol; 2005; (5):22-7. PubMed ID: 16518910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference].
    Boixeda de Miquel D; Martín de Argila C; Pérez Gisbert J
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():29-34. PubMed ID: 9549200
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.